BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 3266280)

  • 61. An investigation of the complement system in patients with periodic disease (results from 29 cases).
    Hartmann L; Lego-Crescioni A; Brecy H; Ollier MP; Herreman G; Mouthon JM; Godeau P
    Biomedicine; 1977 Dec; 26(6):416-24. PubMed ID: 304745
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Perioperative changes of complement (C1q, C3, C4) with cardiopulmonary bypass].
    Wang YT; Xu JX; Zhu YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):86-8, 126-7. PubMed ID: 3264237
    [No Abstract]   [Full Text] [Related]  

  • 63. Immunological studies of human placentae: complement components in pre-eclamptic chorionic villi.
    Sinha D; Wells M; Faulk WP
    Clin Exp Immunol; 1984 Apr; 56(1):175-84. PubMed ID: 6370518
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ; Vergani D; Turney JH; Parsons V; Weston MJ
    Proc Eur Dial Transplant Assoc; 1981; 18():300-4. PubMed ID: 6977138
    [No Abstract]   [Full Text] [Related]  

  • 65. Non-obstructive nephrolithiasis: metabolic and immunopathological studies.
    Jeantet A; Tetta C; Camussi G; Ferrando U; Rotunno M; Thea A; Gaido M; Vercellone A
    Contrib Nephrol; 1985; 49():123-7. PubMed ID: 3913569
    [No Abstract]   [Full Text] [Related]  

  • 66. Immune complexes and complement components in Bell's palsy.
    Jonsson L; Larsson A; Thomander L
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(6):294-301. PubMed ID: 3501560
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Evaluation of C3c, C4 and C1-esterase inhibitor (C1-INH) during unstable angina].
    Danese C; Marcianò F; Ciarla MV; Colotto M; Angrisani L; Ferranti E; Borgia MC
    Minerva Cardioangiol; 2002 Dec; 50(6):667-72. PubMed ID: 12473987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Determination of various fractions of complement (Cl, C3c, C3a, C4) in a population of healthy neonates].
    Zito GA; Grano S; Gallo AB; Papaleo G; Tripodi V
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1043-7. PubMed ID: 6982719
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Complement activation by immunoglobulin does not depend solely on C1q binding.
    Bindon CI; Hale G; Waldmann H
    Eur J Immunol; 1990 Feb; 20(2):277-81. PubMed ID: 2311645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acquired C1-inhibitor deficiency associated with a lupus-like anticoagulant activity.
    Rodriguez M; Ancochea J; De Buen C; Merino JL; Marqués G; Vivanco F
    Ann Allergy; 1988 Nov; 61(5):348-50. PubMed ID: 3142311
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Complement analysis tests].
    Mollnes TE; Nielsen EW; Høgåsen K; Mellbye OJ
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):211-3. PubMed ID: 8430403
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Quantitation of (C1INH)2 C1r-C1s complexes in glomerulonephritis as an indicator of C1 activation.
    Waldo FB; West CD
    Clin Immunol Immunopathol; 1987 Feb; 42(2):239-49. PubMed ID: 3026704
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Sequential study of immunopathological findings of skin in systemic lupus erythematosus (author's transl)].
    Kazama T; Tanaka Y; Ishibashi Y; Morikawa T; Suetsugu T; Sugisaki T; Shiwachi N; Ito S; Yonekura M; Sato S; Kitazawa K; Yamamoto J
    Nihon Hifuka Gakkai Zasshi; 1981 Sep; 91(10):1073-86. PubMed ID: 6976456
    [No Abstract]   [Full Text] [Related]  

  • 75. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
    Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
    Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Increase of serum complement levels in cancer patients with progressing tumors.
    Verhaegen H; De Cock W; De Cree J; Verbruggen F
    Cancer; 1976 Oct; 38(4):1608-13. PubMed ID: 991081
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
    Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
    Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The prognostic value of postoperative serum immunoglobulin and complement component concentrations following gastric resection for carcinoma.
    Janssen CW; Tønder O; Matre R
    Acta Chir Scand; 1985; 151(1):63-7. PubMed ID: 3984658
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Complement components in Nigerians with bronchial asthma.
    Onyemelukwe GC
    Ann Allergy; 1989 Oct; 63(4):309-12. PubMed ID: 2802267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.